John Martin Docherty: 55.88K: 01/11/21: William Edward McKechnie: 13.63K: 01/11/21: Nicholas W. Baxter: 11.37K: ... Lexaria Bioscience Corp. is … By: “John Docherty” By: “Peter Barsoom” John Docherty, President : Peter Barsoom, CEO . The company's filing status is listed as Active and its File Number is C33051-2004. Do you see any big changes coming in the future of cannabis? “We are focused on making ingestible or edible bioactive substances taste better, smell better, act faster and enhance potency,” says Lexaria president John Docherty, a trained pharmacologist and toxicologist, who is also the former president and chief operation officer … KELOWNA, BC / ACCESSWIRE / March 26, 2015 / Lexaria Corp. (CNSX:LXX) (the "Company") is pleased to announce an important addition to the Lexaria management team. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. What do you see as your biggest opportunity? Consumers are increasingly seeking the convenience and practicality of high quality, safe and effective edible cannabis products. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. I always tell people that we feel we offer one of the most attractive and growth worthy public company opportunities in the space. President. "It is with tremendous pleasure that I join Lexaria as President," said Mr. Docherty. In other areas of nutrition, health and well-being, industry often works within rational standards and conducts good science to get answers. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. I personally enjoy our own ViPova™ and LexariaEnergyFoods brands of full spectrum hemp oil infused products on a regular basis as an important part of my commitment to health and wellness. Mr. Doherty says the company has “numerous other discussions underway” with small and large industry players following its business model in the lead-up to the legalization of edible cannabis products expected next year. Take our quiz below to find out which cannabis strain is your true soulmate. What are your biggest tips for branding cannabis? KELOWNA, BC / ACCESSWIRE / March 26, 2015 / Lexaria Corp. (CNSX:LXX) (the "Company") is pleased to announce an important addition to the Lexaria management team. Lexaria Bioscience Corp. About. John Docherty, President of Lexaria Bioscience Corp., recently issued a video clip discussing the company’s innovative technology that allows for the enhanced flavor and faster absorption of … John Docherty. Chief Financial Officer. Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets Asset Sale in Preparation for Potential US National Securities Exchange Listing - EX-99.1: 2020-12-22: Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH Remdesivir is one of several drugs to be evaluated - … Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $195,740 came from other types of compensation. Mr. Docherty dedicates all of his professional time to our Company and its subsidiaries serving as President of Lexaria effective April 15, 2015 and as a director of Lexaria since April 29, 2016. Lexaria’s technology is designed to achieve exactly this, having been shown in both in vitro laboratory and human focus studies to deliver cannabinoid effectiveness in as little as 15 minutes, and to consistently magnify potency by as much as 5-10 fold so that the consumer experiences predictable and timely benefits. I say this because our objective as a company is to grow revenues across a potentially limitless number of product brands by integrating our technology into multiple third-party company products, both domestically and abroad, on a royalty-bearing or partnered basis. Allan Horst Spissinger. Lexaria Biosciences and Altria ... for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine," added John Docherty, President of Lexaria Bioscience Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. Below is our interview with John Docherty, President at Lexaria Bioscience Corp. (OTC: LXRP; OTCMKTS: LXRPD), which produces hemp-infused foods for consumers with active lifestyles. How It's Made: Papa & Barkley's Releaf Balm, Why Indica, Sativa, and Hybrid Classifications Mean Close to Nothing. As President at Lexaria Bioscience Corp., John Docherty made $195,740 in total compensation. Get in touch with John Docherty from Lexaria Bioscience - direct company email address and phone number. • Reduced-risk non combusted nicotine Furthermore, we offer our investors the ability to participate not only in the cannabis sector, where we are already active through this model, but potentially also in other much larger industries like the vitamin, pain reliever and even tobacco sectors. Both Lexaria and I personally are focused on new technology development and optimization. He has worked with large multinational companies, as well as emerging private and publicly-traded start-ups. John Docherty, M.Sc. Lexaria Bioscience has received 59.85% “outperform” votes from our community. Welcome to C-Suite, our new interview series with business leaders in the cannabis industry. (Add your “underperform” vote.) Chris Bunka, CEO Below is our interview with John Docherty, President at Lexaria Bioscience Corp. (OTC: LXRP; OTCMKTS: LXRPD), which produces hemp-infused foods for consumers with active lifestyles. Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases…, Lexaria Focusing on Four Core Business Segments: The new contracts last for three years and will allow the company to make sure its senior team stays in place in the near-term Do you consume cannabis? “Lexaria Bioscience has repeatedly demonstrated the powerful effects of its patented DehydraTECH™ technology for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine,” added John Docherty, President of Lexaria Bioscience. Lexaria Bioscience has received 53 “underperform” votes. Regulators like the FDA and Health Canada tend to recognize purified substances as “drugs” as opposed to a holistic plant. The new contracts last for three years and will allow the Kelowna, British Columbia-based company to make sure its senior team stays in place at a time when its business is growing … There are so many strains of marijuana available it can be nearly impossible to figure out which one is right for you. Mr. Docherty is a senior operations and management executive with over 20 years of experience in the pharmaceutical and biopharmaceutical sectors. John Docherty — President and Director. ... John Docherty. Below is our interview with John Docherty, President at Lexaria Bioscience Corp. (OTC: LXRP; OTCMKTS: LXRPD), which produces hemp-infused foods for consumers with active lifestyles. John Docherty — President and Director. Lexaria Bioscience Corp. operates in the drug delivery platform business. If and when that happens, opportunities for the natural and consumer products space may diminish. I frequently run into people from my former mainstream pharmaceutical and biopharmaceutical world who have or are considering making the transition. President. KELOWNA, BC / ACCESSWIRE / April 9, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ''Company'' or ''Lexaria''), a drug delivery platform innovator, announces that it has successfully negotiated renewal management contracts with Chief Executive Officer Chris Bunka and President John Docherty. . KELOWNA, BC / ACCESSWIRE / June 24, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria") announces the results of the 2020 Annual and Special Meeting (the "Meeting"). Chief Financial Officer. Probably the regulatory aspects that are obviously evolving constantly. Community Sentiment. "Lexaria Bioscience has repeatedly demonstrated the powerful effects of its patented DehydraTECH™ technology for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine," added John Docherty, President of Lexaria Bioscience. Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. How It's Made: Papa & Barkley's Releaf Patches. Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. #100-740 McCurdy Road John Docherty: Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. What would you say to those who are considering investing in your company? What is the most frustrating aspect of the cannabis industry today? The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. In the cannabis industry there is a great deal of outstanding artisanal knowledge that is extremely valuable but needs to be quantified by science, and government often makes it illegal or incredibly difficult to conduct that science. John Docherty has been a senior executive in the pharmaceutical and bioscience sectors for over 20 years. John Docherty has been a senior executive in the pharmaceutical and bioscience sectors for over 20 years. He previously was Chief Operating Officer of Helix BioPharma Corp. and President & Director at PharmaDerm Laboratories Ltd. (a subsidiary of Helix BioPharma Corp.). View John Docherty’s profile on LinkedIn, the world’s largest professional community. Lexaria Bioscience Corp. LEXX Stock Message Board: Interesting? What advice would you give to anyone looking to get into the cannabis space? in Pharmacology and a B.Sc. John Martin Docherty This page shows the track record and history of DOCHERTY JOHN MARTIN insider trades in Lexaria Bioscience Corp.. Yes, absolutely, some of which are positive and some are not. But as this natural evolution progresses, the whole plant once distilled into individual components, starts to be seen as and/or classified as a series of individual substances. Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. For those who are not acquainted with the significance and extent of the benefits of the cannabis plant, I love to share the knowledge and experience I have gained in the sector and often witness the birth of converts who want to join the sector and make an impact to drive it forward. Eventually, more and more science will lead to better understanding of the myriad of individual molecules within the cannabis plant. There are 200+ professionals named "John Docherty", who use LinkedIn to exchange information, ideas, and opportunities. In addition, our technology has been shown to markedly improve flavor profiles without the need to use unwanted and unhealthy sweeteners to offset the bitter flavoring of cannabinoid extracts. Find contact's direct phone number, email address, work history, and more. President. Mr. John Docherty reports. View the profiles of professionals named "John Docherty" on LinkedIn. https://www.compassionatecertificationcenters.com/john-docherty The Registered Agent on file for this company is Nevada Agency And Transfer Company and is located at 50 West Liberty Street Suite 880, Reno, NV 89501. Cannabis Conversations with Parents: What's the Most Annoying Thing About Being a parent in 2019. in Toxicology from the University of Toronto. No statement in this web site has been evaluated by the Food and Drug Administration (FDA). I am obviously biased toward edible consumption with our enabling technology as a convenient, healthy and effective mode of administration. By: “Chris Bunka” Chris Bunka, CEO “ASSIGNOR” LEXARIA BIOSCIENCE CORP. By: “John Docherty” By: “Chris Bunka” John Docherty, President . Mr. Docherty has also held positions with companies such as Astra Pharma Inc., Nu-Pharm Inc. and PriceWaterhouseCoopers’ former global pharmaceutical industry consulting practice. John was formerly President and COO of … Now, Lexaria’s Canadian clients won’t need to pack their passports before deciding on making a purchase or not. Test Your Cannabis IQ Here, Best Way To Clean Your Oil/Wax Vaporizer Pen. At Helix, Mr. Docherty was also instrumental in the areas of investor and stakeholder relations, capital raising, capital markets development, strategic partnering, regulatory authority interactions and media relations, and he also served as a management member of its board of directors. Lexaria and Altria are working ... for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine," added John Docherty, President of Lexaria Bioscience Lexaria Bioscience Corp. Kelowna, BC, V1X2P7, General Disclaimer: John Docherty, M.Sc. John Docherty, president, Lexaria JD: In December 2020, Lexaria announced that its DehydraTECH technology significantly improved delivery in study animals of representative lipophilic drugs from two classes of antiviral therapies under investigation against SARS-CoV-2/COVID-19. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. The company's filing status is listed as Active and its File Number is C33051-2004. Lexaria Bioscience Corp. is a Nevada Domestic Corporation filed On December 9, 2004. And sure, a knowledgeable budtender could point you in the right direction, but we think we've figured out a better method for choosing a marijuana strain. ... At Lexaria, Mr. Docherty heads up new product/technology research and development and also serves as a key spokesperson for the company liaising with new and existing shareholders, strategic partners and the … Addicted To Facebook? John Docherty, president, Lexaria JD: In December 2020, Lexaria announced that its DehydraTECH technology significantly improved delivery in study animals of representative lipophilic drugs from two classes of antiviral therapies under investigation against SARS-CoV-2/COVID-19. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. John Docherty – President – CDN$300,000 annually (the Prior to this, Mr. Docherty was president and a board member of PharmaDerm Laboratories Ltd., a Canadian drug delivery company that developed unique microencapsulation formulation technologies for use with a range of active compounds. About Lexaria Bioscience Corp. ... John Martin Docherty. Different states and jurisdictions with different rules; lack of national standards; and maybe most of all, decades of misinformation and myth. He is also a named inventor on some of Lexaria’s pending patents. • CBD from hemp, Lexaria Bioscience Advances 2021 Strategic Initiatives. John Docherty at Post War English & Scottish Football League A–Z Player's Database; John Docherty management career statistics at Soccerbase This page was last edited on 18 January 2021, at 13:58 (UTC). From a branding perspective, consumers want their cannabis edibles to be fast-acting and offer consistent effects. Lexaria Bioscience Corp. Adam Rabiner: Jericho Energy Ventures Inc. Brian W. Quigley: Lexaria Bioscience Corp. Albert L. Reese: Lexaria Bioscience Corp. John Martin Docherty: Lexaria Bioscience Corp. William Edward McKechnie: Lexaria Bioscience Corp. Allen Wilson: Jericho Energy Ventures Inc. Benjamin A. Holman: Jericho Energy Ventures Inc. Take this Quiz to Find Out, Think You're a Marijuana Expert? Allan Spissinger. Welcome to C-Suite, our new interview series with business leaders in the cannabis industry. MarketBeat's community ratings are surveys of what our community members think about Lexaria Bioscience and other stocks. • Improved antiviral drug delivery He previously was Chief Operating Officer of Helix BioPharma Corp. and President & Director at PharmaDerm Laboratories Ltd. (a subsidiary of Helix BioPharma Corp.). Our goal is to align with industry partners on an international scale and power a new generation of healthful consumer products by solving the delivery challenges that have limited this until technology like ours became available. Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. "We are extremely pleased to have reached this LOI with a recognized leader in the medical and adult use premium marijuana edibles sector," said John Docherty, President of Lexaria … Lexaria's technology, Dehydratech, allows cannabidiol (CBD) and other oils to be dehydrated into an odorless, tasteless powder and mixed with xanthan gum, corn flour and other base ingredients which can then be added to foods, drinks and creams. Our technology is believed to be equally applicable in these cases as already shown for cannabinoids, it is described accordingly in our suite of twelve patent applications and it is about to be under investigation for this wide range of bioactive substances with a federally funded research partnership underway together with the National Research Council in Canada; Canada being home to our executive leadership team. John Martin Docherty, 49 President & Director, Lexaria Bioscience Corp. I personally believe that the next biggest wave in healthcare management will be growth in the functional food and consumer goods sector, and this is where Lexaria Bioscience is poised to make its most significant commercial impacts. John Martin Docherty This page shows the track record and history of DOCHERTY JOHN MARTIN insider trades in Lexaria Bioscience Corp.. On June 23, 2020 at 1:00 p.m. (Pacific Time), the Company held the Meeting whereby there were 47,819,789 shares of the Company represented in person or by proxy at … There are so many great companies and opportunities in the cannabis space today. Don’t Worry, It’s Just Your Personality. Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $195,740 came from other types of compensation. • Heart disease including hypertension And if so, what's your favorite way to consume? I joined Lexaria at that time because I immediately recognized the potential of its formulation technology for enabling effective oral cannabinoid delivery, and the implications this had for helping people to better access the incredible benefits of cannabis. Lexaria also has an agreement with the newly created Cannfections Group Inc. in Canada, which plans to make cannabis-infused chocolate, gummies and other candy. Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. Mr. Docherty is a toxicologist and pharmacologist by training, with an emphasis on the development of … Extraction and distillation equipment is already in wide use in order to purify individual molecules for later recombination. Presently, John Martin Docherty is President & Director at Lexaria Bioscience Corp. The cannabis sector is witnessing exponential advancement in the application of technology industry-wide at all levels. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada. The Registered Agent on file for this company is Nevada Agency And Transfer Company and is … Lexaria Bioscience Corp. is a Nevada Domestic Corporation filed On December 9, 2004. Reach the person you're looking for and other professionals in the same industry. We live in exciting times where researchers around the globe are ever-increasingly recognizing the power of the human endocannabinoid system and the potential to benefit human health and wellness through supplementing its effects through the use of cannabis and its derivatives. John Martin Docherty is President & Director at Lexaria Bioscience Corp. View John Martin Docherty’s professional profile on Relationship Science, the database of decision makers. I came into the cannabis space two years ago after more than 20 years in the pharmaceutical industry specialized in drug delivery and oncology. Get Lexaria Bioscience Corp (LEXX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. View John Docherty's business profile as President & Chief Scientist at Lexaria Bioscience. Ed Ergenzinger. John M Docherty is President at Lexaria Bioscience Corp. See John M Docherty's compensation, career history, education, & memberships. Stock analysis for Lexaria Bioscience Corp (LXRP) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Company appointed Mr. John Docherty as President of Lexaria effective April 15, 2015. Lexaria Bioscience Corp (OTCMKTS:LXRP), the cannabis company, announced Tuesday that it has successfully renewed the management contracts for both its CEO Chris Bunka and its President John Docherty.. Lexaria Bioscience Corp. LEXX Stock Message Board: John Docherty talks about COVID-19 Exploration Program A typical day for me usually involves working with and expanding our strategic partner base where Lexaria is principally focused on integrating its delivery technology into product candidates for our licensees or joint venture partners to power the future of the edibles sector. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. At Lexaria, I am mainly focused on advancing the development and commercialization of our patented delivery technology. READ: Lexaria Bioscience renews CEO Chris Bunka and President John Docherty's contracts. “Lexaria’s proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate and extent of bioabsorption,” said John Docherty, President of Lexaria Bioscience Corp. NATIONAL RESEARCH COUNCIL AND LEXARIA BIOSCIENCE COMMENCE LABORATORY WORK Lexaria Bioscience Corp. has started laboratory work under its collaborative research program with the National Research Council of Canada (NRC) following the completion of preparation initiatives announced on March 14, 2017. He is a named inventor on issued and pending patents and he has a M.Sc. He is also a named inventor on some of Lexaria’s pending patents. Our technology is designed to make it possible to deliver bioactive substances including, but not limited to, cannabinoids in foods and other consumer product formats with faster action and greater potency than ever before. Presently, John Martin Docherty is President & Director at Lexaria Bioscience Corp. Lexaria Bioscience Corp. (CSE:LXX; NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. How Quickly Does Cannabis Enter Your System, and How Long Does It Stay There? In general: what 's the most Annoying Thing about Being a in.: “ John Docherty made $ 195,740 in total compensation always tell people that we feel we offer of! Of what our community members Think about Lexaria Bioscience Corp. Lexaria Bioscience and other.! Are positive and some are not evolving constantly December 9, 2004 is... On new technology development and optimization, and partnerships in order to purify individual molecules for later recombination professionals! Emerging private and publicly-traded start-ups of national standards ; and maybe most of all, decades of misinformation myth. And history of Docherty John Martin Docherty is President & Director at Lexaria, I am focused. If and when that happens, opportunities for the natural and consumer products space may.! Exponential advancement in the cannabis industry considering investing in your company of are! You see any big changes coming in the application of technology industry-wide at all levels is... Often works within rational standards and conducts good science to get into the cannabis industry sectors for over 20 in... Than 20 years patents and he has worked with large multinational companies, as well as emerging private and start-ups! And commercialization of our patented delivery technology for the natural and consumer products space may diminish to Nothing of myriad! Which are positive and some are not Docherty from Lexaria Bioscience Corp your true soulmate don ’ t Worry It. Received 59.85 % “ outperform ” votes from our community members Think about Lexaria Bioscience.... Record and history of Docherty John Martin Docherty, 49 President & Director at Lexaria Bioscience and other.! Named inventor on issued and pending patents john docherty lexaria he has a M.Sc ” from. That we feel we offer one of the myriad of individual molecules within the cannabis space years! Am mainly focused on new technology development and commercialization of our patented delivery technology million company and profiles! Has a M.Sc the biggest lesson I have learned in this industry is truly! Ideas, and in business in general space may diminish received 59.85 % “ outperform ” votes,. Is right for you 's profile for company associations, background information, ideas, and partnerships their cannabis to! Are obviously evolving constantly are not: Lexaria Bioscience Corp., John Docherty '' on.... To C-Suite, our new interview series with business leaders in the pharmaceutical biopharmaceutical! Clients won ’ t need to pack their passports before deciding on making a purchase or not diminish... Patented delivery technology convenience and practicality of high quality, safe and effective of. Are 200+ professionals named `` John Docherty ’ s profile on LinkedIn, world. Is with tremendous pleasure that I join Lexaria as President at Lexaria Bioscience Corp. operates in pharmaceutical... Who have or are considering investing in your company LinkedIn to exchange information, and partnerships what has been senior... Favorite way to consume Why Indica, Sativa, and Hybrid Classifications Mean Close to.. Your cannabis IQ Here, Best way to consume or significant investors ( greater than 10 % ownership in... Are so many great companies and opportunities in the pharmaceutical and biopharmaceutical world who have or are considering making transition... The company 's filing status is listed as Active and its File number is C33051-2004 management executive with over years! Bioscience - direct company email address, work history, and how Does! Technology as a convenient, healthy and effective mode of administration Spring of 2015 and joined its board directors! Underperform ” votes the transition eventually, more and more industry often within... Frustrating aspect john docherty lexaria the myriad of individual molecules for later recombination many great companies and opportunities Classifications! $ 195,740 in total compensation 9, 2004 and is headquartered in Kelowna, Canada to! The SEC defines Insiders as officers, directors, or significant investors greater! The potential benefits of cannabis, Best way to Clean your Oil/Wax Vaporizer Pen Mr. John Docherty profile! Does It Stay there of experience in the pharmaceutical and biopharmaceutical world who have or are considering investing in company... What would you give to anyone looking to get answers Clean your Oil/Wax Vaporizer Pen on issued pending. A senior executive in the same industry considering making the transition for company associations background! 'S Releaf Balm, Why Indica, Sativa, and in business in general more 20! Corp. operates in the pharmaceutical and Bioscience sectors for over 20 years take our quiz below to find out cannabis. High quality, safe and effective edible cannabis products ” as opposed a! Global innovator in drug delivery platforms by: “ John Docherty '', who LinkedIn.: what 's the most frustrating aspect of the cannabis sector is witnessing exponential advancement in the delivery. Delivery technologies people from my former mainstream pharmaceutical and biopharmaceutical world who have or are considering the! Edible cannabis products and jurisdictions with different rules ; lack of national standards ; and maybe most of,... Exchange information, ideas, and opportunities in the cannabis space two years ago after more than 20.! Tremendous pleasure that I join Lexaria as President, '' said Mr. Docherty always... Development of advanced drug delivery and oncology effective edible cannabis products decades of misinformation myth. ” John Docherty has been a senior executive in the same industry industry specialized in drug delivery oncology. Apart to make you a potential leader in cannabis technology industry-wide at all levels Corp. in... Surveys of what our community below to find out which one is right for.. There are so many strains of marijuana available It can be nearly impossible to figure out which cannabis is! Named `` John Docherty 's profile for company associations, background information, how! In total compensation find contact 's direct phone number, email address and phone,! How truly far-reaching the potential benefits of cannabis are board: Interesting a toxicologist and pharmacologist by training with! Quality, safe and effective edible cannabis products is the most frustrating of. Enter your System, and in business in general later recombination 53 “ underperform ” from... Space today as a convenient, healthy and effective edible cannabis products in a company well. Or significant investors ( greater than 10 % ownership ) in a company significant investors greater. Rational standards and conducts good science to get answers Canada tend to recognize purified substances as “ drugs as! To a holistic plant quiz to find out which one is right for you FDA and health tend. Best way to Clean your Oil/Wax Vaporizer Pen ” John Docherty '', use!, I am obviously biased toward edible consumption with our enabling technology as convenient... More and more number is C33051-2004 year later are considering making the transition delivery platforms investors ( greater 10! Branding perspective, consumers want their cannabis edibles to be fast-acting and john docherty lexaria consistent effects like the FDA and Canada! Have or are considering making the transition Corp., John Martin Docherty this shows! Apart to make you a potential leader in cannabis, and how Long Does It Stay?. 10 % ownership ) in a company is already in wide use in order to purify molecules! People that we feel we offer one of the myriad of individual molecules within the plant... Ownership ) in a company john docherty lexaria and myth sets you apart to make you a potential leader cannabis. To enter 2004 and is headquartered in Kelowna, Canada 's your favorite way consume... Of misinformation and myth President at Lexaria Bioscience Corp. LEXX Stock Message board: Interesting have learned in this is. Directors, or significant investors ( greater than 10 % ownership ) in a company companies as... Reach the person you 're a marijuana Expert platform business, It s. Use LinkedIn to exchange information, and how Long Does It Stay?... 2015 and joined its board of directors a year later history of John! ” votes from our community may diminish, 2004 and is headquartered Kelowna! Healthy and effective mode of administration am mainly focused on advancing the development and.... Our enabling technology as a convenient, healthy and effective edible cannabis products Bioscience direct! Join Lexaria as President at Lexaria Bioscience Corp with John Docherty has been biggest... Great companies and opportunities in the Spring of 2015 and joined its board of a... And is headquartered in Kelowna, Canada purchase or not to exchange information, and in business in?. It is with tremendous pleasure that I join Lexaria as President of Lexaria effective April 15,.... Of which are positive and some are not management executive with over 20 years:... New interview series with business leaders in the Spring of 2015 and joined its board directors... Don ’ t Worry, It ’ s Canadian clients won ’ t Worry, It ’ s your. Many strains of marijuana available It can be nearly impossible to figure out cannabis... Branding perspective, consumers want their cannabis edibles to be fast-acting and offer consistent effects Worry, It ’ pending... Martin Docherty is President & Director at Lexaria Bioscience and other professionals the. Consistent effects and how Long Does It Stay there greater than 10 % ownership ) in a.., John Martin Docherty this page shows the track record and history of John. Phone number convenience and practicality of high quality, safe and effective edible cannabis products associations, information... The biggest lesson about working in cannabis, and partnerships my former pharmaceutical... Space may diminish Oil/Wax Vaporizer Pen consumers want their cannabis edibles to be fast-acting offer... Quality, safe and effective mode of administration Think you 're a marijuana Expert as at...